Levocetirizine Dihydrochloride
Product Images NDC 66336-720

2 FDA label images from Dispensing Solutions, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 66336-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levocetirizine Dihydrochloride Structural Formula (09488ea4 0f6d 4924 A770 44d9176bab90 01)

Levocetirizine Dihydrochloride Structural Formula (09488ea4 0f6d 4924 A770 44d9176bab90 01)
Chemical structure of Levocetirizine Dihydrochloride, showing its molecular framework including phenyl rings, a piperazine ring, and associated hydrochloride counterions.*
FDA Label Image

Ndc 66336-0720-xx (Ndc 66336 0720 Xx Teva)

Ndc 66336-0720-xx (Ndc 66336 0720 Xx      Teva)
Label for Levocetirizine Dihydrochloride 5 mg tablets, NDC 66336-0720, Product #845-XX, manufactured for Teva Pharmaceuticals USA. The label includes dosage instructions to take one tablet orally once daily in the evening and cautions about drowsiness and operating machinery. Packaged exclusively by Dispensing Solutions, Inc. in Santa Ana, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.